Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07062601

Etomidate and Esketamine on Postoperative Pain After Tonsillectomy Undergoing Children

Effect of Etomidate and Esketamine on Postoperative Pain After Tonsillectomy Undergoing Children With General Anesthesia

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
64 (estimated)
Sponsor
Anqing Municipal Hospital · Academic / Other
Sex
All
Age
2 Years – 10 Years
Healthy volunteers
Not accepted

Summary

Objective: To explore the effect of etomidate and esketamine on postoperative pain after tonsillectomy in children. Methods: Investigators enrolled 64 children with American Society of Anesthesiologists (ASA) physical status I and II, aged 2-10 years, and scheduled for elective undergoing tonsillectomy with general anesthesia. All the enrolled patients were randomly divided into etomidate and fentanyl group (Group A) and etomidate and esketamine group (Group B). In the etomidate-fentanyl group (group A), 0.3 mg/kg etomidate and 4 µg/kg fentanyl were given at the induction of anesthesia, followed by continuous infusion of propofol at 4-12 mg/kg/h and remifentanil at 3-6 µg/kg/h until the end of the surgery, respectively; in the etomidate-esketamine group (group B), induction of anesthesia with 0.3 mg/kg etomidate and 0.5 mg/kg esketamine , followed by continuous infusion of propofol at 4-12 mg/kg/h and remifentanil at 3-6 µg/kg/h until the end of the operation. Anesthesiologists who were unaware of the grouping recorded the FlACC Pain Scale at 2 h, 8 h, and 24 h after surgery.

Conditions

Interventions

TypeNameDescription
DRUGEtomidate and fentanyl groupIn the etomidate-fentanyl group (group A), 0.3 mg/kg etomidate and 4 µg/kg fentanyl were given at the induction of anesthesia, followed by continuous infusion of propofol at 4-12 mg/kg/h and remifentanil at 3-6 µg/kg/h until the end of the surgery, respectively.
DRUGEtomidate and esketamine groupIn the etomidate-esketamine group (group B), induction of anesthesia with 0.3 mg/kg etomidate and 0.5 mg/kg esketamine , followed by continuous infusion of propofol at 4-12 mg/kg/h and remifentanil at 3-6 µg/kg/h until the end of the operation

Timeline

Start date
2025-07-10
Primary completion
2025-11-10
Completion
2025-11-15
First posted
2025-07-14
Last updated
2025-07-14

Source: ClinicalTrials.gov record NCT07062601. Inclusion in this directory is not an endorsement.